WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

May 14, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-10

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-10	Common Stock	A	38.0500	$65.5100	Acquired	20508.3648	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	503168.4076	Direct
Common Stock	1335.6398	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.